383 related articles for article (PubMed ID: 26088453)
1. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis.
Seung BJ; Cho SH; Kim SH; Lim HY; Sur JH
PLoS One; 2020; 15(2):e0229031. PubMed ID: 32059046
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.
De Maria R; Olivero M; Iussich S; Nakaichi M; Murata T; Biolatti B; Di Renzo MF
Cancer Res; 2005 Feb; 65(3):907-12. PubMed ID: 15705889
[TBL] [Abstract][Full Text] [Related]
4. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
[TBL] [Abstract][Full Text] [Related]
5. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J
Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
7. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
8. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.
Dutra AP; Granja NV; Schmitt FC; Cassali GD
Braz J Med Biol Res; 2004 Nov; 37(11):1673-81. PubMed ID: 15517084
[TBL] [Abstract][Full Text] [Related]
10. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
[TBL] [Abstract][Full Text] [Related]
12. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
13. HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Gamba Cde O; Miranda FF; Alves MR; Rocha RM; de Barros AL; Cassali GD
PLoS One; 2016; 11(8):e0160419. PubMed ID: 27490467
[TBL] [Abstract][Full Text] [Related]
14. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
15. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
16. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
17. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
18. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M
Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of mammaglobin-B in canine mammary tumors.
Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R
BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015
[TBL] [Abstract][Full Text] [Related]
20. Cross-species oncogenic signatures of breast cancer in canine mammary tumors.
Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S
Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]